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Abstract 
 
Objectives 
        Chemically, nicardipine is 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-
3,5-pyridine dicarboxylic acid methyl-2-[methylphenylmethyl) aminomethyl 
ester (Merck index 2001). The presence of the ester linkage in its structural 
formula renders it susceptible to hydrolysis by both acids and alkalies. The 
possible degradation of the drug under such conditions initiated the present 
study. 
Reviewing the literature, revealed that, only the effect of light on the 
stability of nicardipine has been studied. This led  to study the degradation of 
this compound under normal and stress conditions such as elevated temperature, 
a hostel of chemical environment and a combination of these conditions. The 
aims of this work are : 
1. Development of a stability-indicating HPLC method for 
             nicardipine HCl and its degradation products. 
2. To evaluate the kinetic parameters of the degradation reaction. 
3. To gain knowledge on the mechanism of decomposition. 
4. To isolate and identify the degradation product(s). 
5. To indicate at what pH the drug is stable. 
Method: 
  
A proposed HPLC was adopted to follow the kinetics of the degradation of 
nicardipine HCL. The chromatogrophic seperation was performed on Hypersil, 
BDS-C18 , 15cm X 3.9 mm id, column, at ambient temperature with UV 
detection at 254nm . A mixture of 20% (v/v) aqueous 0.01M sodium acetate 
/acetic acid buffer (pH 4.5) and 80% acetonitrile was used as the mobile phase 
at flow rate of 1.5ml/min., losartan was used as internal standard. 
Result: 
The method allows complete base line seperation with a good resolution factor 
, 0.17%  RSD and 99.78%  recovery. 
Degradation kinetics was studied in acid and alkaline media and found to be 
first order. In acid  media the rate constant (K) and the half-life (t1/2) were 
found to be 1.38x10-3 minutes-1 and 502 minutes respectively. 
In alkaline media the studies were carried at room temperature and at 700,800, 
900 and 1000 C ,using  increasing concentrations of NaOH  (0.1,0.2,0.3, 
0.4,0.5M). At room temperature increasing the concentration of  NaOH 
resulted in increasing the rate of degradation and the rate constant  and 
decreasing the half-life. 
The effect of different buffers with differents pH values on the rate of 
degradation of nicardipine was studied and the increase in the rate of 
degradation was found to follow the order citrate >  phosphate> borate> 
acetate. 
The degradation products were isolated and identified. 
  
Conclusion: 
A rapid precise and specific HPLC method has been developed for the 
determination of nicardipine alone or in the presence of its degradation 
products. The kinetics parameters were determined and the drug was found to  
be stable at pH 4.5. The rate of degradation increases in alkaline media . 
Citrate buffer exerts more catalytic activity than the other three buffers of 
which acetate apparently has no effect on the rate of degradation of nicardipine 
hydrchloride. 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
  
 ﻣﺴﺘﺨﻠﺺ ﺍﻟﺒﺤﺚ
 ﺍﻻﻫﺪﺍﻑ
 ﻛﻴﻤﻴﺎﺋﻴﺎ ﻋﻠﻲ ﺭﻭﺍﺑﻂ ﺍﻻﺳﺘﺮﺍﺕ ﺍﻟﱵ ﲡﻌﻠﻪ ﺳﻬﻞ ﺍﻟﺘﻔﻜﻚ ﺑﺎﻻﲪﺎﺽ         ﳛﺘﻮﻱ ﺍﻟﻨﻴﻜﺎﺭﺩﻳﺒﲔ
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  ﻭﳍﺬﻳﻦ ﺍﻟﺴﺒﺒﲔ ﺍﺟﺮﻳﺖ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﻭﺗﺘﻠﺨﺺ ﰲ ،         ﻫﻮ ﺍﻷﺛﺮ ﺍﻟﻮﺣﻴﺪ ﺍﻟﺬﻱ ﲤﺖ ﺩﺭﺍﺳﺘﻪ 
         :       ﺍﻻﰐ
  0      ﺇﺳﺘﻨﺒﺎﻁ ﻃﺮﻳﻘﺔ ﲢﻠﻴﻠﻴﺔ ﻟﺘﻘﺪﻳﺮ ﺍﻟﻌﻘﺎﺭ ﻭﻧﻮﺍﺗﺞ ﺗﻔﻜﻜﻪ1     
                                        0  ﻟﻌﻘﺎﺭ ﻫﻴﺪﺭﻭﻛﻠﻮﺭﻳﺪ ﺍﻟﻨﻴﻜﺎﺭﺩﻳﺒﲔﻔﻜﻚ ﺩﺭﺍﺳﺔ ﺍﻟﺘ       2   
  0 ﻣﺘﺎﺑﻌﺔ ﻃﺮﻳﻘﺔ ﺍﻟﺘﻔﻜﻚ ﺍﻟﻜﻴﻤﺎﺋﻲ ﻟﻠﻌﻘﺎﺭ       3     
  0 ﺍﻟﻌﻘﺎﺭ ﺗﻔﻜﻚ ﻓﺼﻞ ﻧﻮﺍﺗﺞ     4      
  ﻟﻌﻘﺎﺭ  ﺪﻳﺪ ﺍﻻﺱ ﺍﳍﺎﻳﺪﺭﻭﺟﻴﲏ ﻟﺜﺒﺎﺗﻴﺔ ﺍﲢ      5      
  ﻣﻨﻬﺠﻴﺔ ﺍﻟﺒﺤﺚ
ﻚ ﺎﺭ ﻭﺩﺭﺍﺳﺔ ﺣﺮﻛﻴﺘﻪ ﻭﺫﻟﻗﺮﻭﰲ ﻋﺎﻟﻴﺔ ﺍﻟﻜﻔﺎﺀﺓ  ﻟﺘﻘﺪﻳﺮ ﺍﻟﻌﻘﰎ ﺍﺳﺘﻨﺒﺎﻁ ﻃﺮﻳﻘﺔ ﲢﻠﻴﻞ ﻛﺮﻭﻣﺎﺗﻮ
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  :ﺍﻟﻨﺘﺎﺋﺞ
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The following list of commonly used symbols and abbreviations are 
listed, for convenience in referring to them cited in this thesis. 
 
 
 FULL EXPRESSION   
 
HPLC High performance liquid chromatography. 
 
IR Infra-red. 
 
l Litre. 
 
ml Millilitre. 
 
m.p. Melting point. 
 
NMR Nuclear magnetic resonance. 
 
RH Relative humidity. 
 
TLC Thin-layer chromatography. 
 
UV Ultra-violet. 
 
λmax Wavelength of maximum absorbance. 
 
K Reaction rate constant. 
 
t1/2 Half-life time. 
 
R Gas Constant (1.987 Cal/mol. deg) 
 
Ea Activation energy (K. Cal/mol). 
 
T Absolute temperature (t°C + 273). 
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SD Standard deviation. 
 
r Correlation coefficient. 
 
p = 0.05 Probability at 95% level. 
 
µg Microgram. 
 
min Minute. 
 
sec Second 
 
nm Nanometer = 10-9 meter. 
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I.   INTRODUCTION 
I.0 Drug degradation and stability-indication in today’s regulating 
environment 
 
 Drug degradation is a serious problem which renders the job of quality 
control analyst very critical. The degradation is usually brought about by any of 
the following methods, namely, oxidation, hydrolysis and photodecay. 
 Any type of degradation depends on various factors e.g. hydrolysis 
depends on the presence of ester or amide groups where the acidic and 
alcoholic moieties can be splitted. Several papers (El-Gindy et al.  
1998),(Quary et al. 1998),(Gutrienez  et al . 1998), (Dine et al.1998) and 
(Yesilada et al.1998) can be cited in the literature demonstrating the occurrence 
of various decomposition products. These products were further investigated by 
separation into different components and identification of these components by 
the usual physicochemical methods such as I.R. spectrometry, NMR 
spectrometry, UV spectroscopy, elemental analysis and TLC. Drug degradation 
is usually associated with stability of the drug. 
 Drugs that possess certain labile functional groups are prone to 
decomposition particularly when formulated in liquid preparations. The assay 
of these formulations can be carried out by a suitable stability indicating 
method, e.g. HPLC which is by far the method that is most widely used today 
as a stability indicating method.  
  2
Stability-indicating methods are required for the assay of drug formulations 
where the intact drug and its degradant coexist. 
 Quantitative methods which do not differentiate between the drug and its 
degradent are not recommendable for the assay of unstable drug formulations. 
 
I.1 Kinetics of drug degradation 
 The chemical action of a solvent and other solutes on the drug in 
solution is of prime importance. A systemic approach to its understanding and 
quantification is to consider the rate of degradation of such a drug as 
proportional to the concentration of the reactants in equilibria which preceed 
such a rate-determining step. The rate of drug transformation is given in 
concentration, C, change per unit of time; (mol.L-1unit-time-1). In most 
solvolytic reactions with constant conditions of temperature, pH, buffer kind 
and concentration , the rate of change per unit of time is proportional to the first 
power of the concentration of the drug being transformed. 
 dC/dt (M/Lsec) = KC (sec-1 × M/L), .............................................. [1] 
 The rate is considered as apparent first-order if it varies as the first 
power of the concentration, C, of the substrate. On integration of equation [1], 
the logarithm of the concentration (when plotted against time) is a straight line 
with slope = K/2.303. 
 log C = − Kt /2.303 + log Co, ......................................................... [2] 
  3
or the logarithm of the fraction of substrate untransformed when plotted against 
time is a straight line of the same slope  
 log C/Co = −Kt / 2.303, ................................................................... [3] 
where Co is the original concentration and K is in reciprocal time units 
(Keaneth et al .1984). 
 
I.2 Factors affecting drug degradation 
I.2.1 Specific acid-base solvolysis 
  The simplest catalysis for solvolysis are hydrogen ions and hydroxyl ions. In 
general, hydroxyl ion catalysis is considered negligible when a hydrogen ion 
catalysed transformation is operative, and vice versa, so that one method of 
determining K1 is to plot the observed rate constant, K1, obtained from the 
slope of the plot of data according to equation [2] against the maintained [H+]. 
 The specific bimolecular rate constants are defined in terms of the ratio of the 
apparent first-order rate constant and the concentration or activity of the 
catalytic species.  
 Ester hydrolysis is most generally catalysed only by H+ and −OH 
(specific acid-base catalysis) but consumes −OH, so that if K2 = K/[−OH] is to 
be determined, then the molar concentration of strong alkali should exceed the 
concentration of substrate by at least ten-fold, e.g. [−OH] > 10 Co when [−OH] 
is taken equivalent to [NaOH]. It is a similar situation for amides when H+ are 
taken up by the liberated amines, the concentration of strong acid must greatly 
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exceed the substrate concentration for pseudo first-order techniques to be used 
in the calculation of the apparent bimolecular rate constant K1.( Keaneth et al. 
1984). 
 
I.2.2 General acid-base catalysis 
 Not only may H+ or −OH alone catalyse the decomposition of drugs in 
solution, but charged species contributed from excipients or buffers may do so 
also. An appropriate method to evaluate general acid-base effects is to 
determine the apparent first-order rate constant in the buffered vehicle and 
subtract those rate contributions which can be studied separately, such as 
K1[H+], K2 [−OH] … the excess in degradation rate can be assigned to general 
acid-base catalysis . 
 
I.2.3 Effect of temperature 
   The reaction rate is expected to be proportional to the number of collisions 
per unit time. Since the number of collisions increases as the temperature 
increases, we would expect the reaction rate to increase with increasing 
temperature. Experimentally, the reaction rate constant is observed to have an 
exponential dependence on temperature. 
 K = A exp (Σ Ea / RT) 
where K is the reaction rate constant of any order, A and Ea are constants, and 
T is the absolute temperature (t°C + 273.16°). Ea is called the activation energy 
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of the chemical reaction. This equation (the Arrhenius equation) can be written 
in several equivalent forms as follows: 
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where K1 and K2 are the rate constants at temperatures T1 and T2, respectively. 
The interpretation of Ea is as follows: as the reaction proceeds from reactants to 
products, the system must pass through a state whose energy is greater than that 
of the initial reactants. This “barrier” is what prevents the reactants from 
“immediate” becoming products; the activation energy is a measure of this 
barrier ( Keaneth et al. 1984, Donald et al. 1970).  
 Equation [1] indicates that a graph of log K against 1/T will be linear 
with a slope of -Ea / R × 2.303, where R is the gas constant (1.987 
calorie.mol−1degree). Such plots are called Arrhenius plots. From this plot, Ea 
can be determined. Also, the specific rate-constants for any temperature can be 
calculated from a knowledge of these constant and applied to the prediction of 
the overall apparent first-order rate constant. 
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I.3 Accelerated stability study 
 The accelerated stability study enables the rate constant (at a known 
temperature) and the energy of activation to be calculated from a single 
experiment (Irwin 1990). This test has some advantages over conventional 
methods for determining the stability of pharmaceutical preparations (Cole and 
Leadbeater1965). These advantages are: 
1. The data required to calculate the stability of the compound are 
obtained in a single experiment lasting one day, rather than in a series of 
experiments, which may last for several weeks. 
2. No preliminary experiments are required to determine the 
optimum temperature for the accelerated storage test. 
3. The linearity of the plot of Log (C) against ( t) confirms that the 
correct order of reaction for the decomposition has been assumed. 
The accelerated stability study is based on the Arrhenius equation which 
relates the rate constant of a reaction with temperature, thus: 
)11(
303.2 10
01 TTR
E
KLogKLog a −+=  
This equation is an approximation but nevertheless it permits the calculation of 
rate constants, over a range of temperatures, which are in reasonable agreement 
with those determined experimentally, and it has been used as a basis for 
accelerated stability studies.  
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 As for the stability of pharmaceutical product, it may be defined as the 
capability of a particular formulation in a specific container/closure system to 
remain within its physical, chemical, microbiological, therapeutic, 
toxicological, protective and informational specifications ( Kommanaboyina 
and Rhodes 1999). It is convenient to classify degradation of pharmaceutical 
products as being chemical, physical or biological. However, in many instances 
these distinctions are not complete. For many drugs or devices more than one 
mode of degradation may be possible. In general, we may classify the adverse 
effects of the instability of a pharmaceutical product as modifying efficacy, 
safety or ease of use or patient acceptability. In terms of efficacy, the most 
obvious effect is dose potency of drug. Usually 90% of label claim is regarded 
as being the lowest acceptable value of potency ( Kommanaboyina and Rhodes 
1999  ). 
 
I.4 Interpretation of kinetic data 
 The rate constants are parameters that describe the time course of the 
reactions. To study the factors that determine the magnitude of the rate 
constant, we must adopt a molecular view point, that is, we must consider 
reaction mechanisms. These mechanism will enable us to understand, at least in 
qualitative terms, the dependence of reaction rates on both chemical structure 
and reaction conditions, and consequently, to make useful estimates of the 
effects of changing conditions on rate constants ( Keaneth et al. 1984) . 
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I.4.1 The transition state theory 
Consider the important class of reactions in which two molecules A and 
B react to form products. A successful theory of the rates of such reactants can 
be built on  three assumptions: 
1. In order for the reactants A and B (the initial state) to be 
transformed to the products (the final state), they must pass 
through some intermediates states (the transition state) that is 
of higher energy than either the initial or final states. 
2. The molecules in the transition state are in equilibrium 
with those in the initial state. 
3. The rate of reaction is proportional to the concentration of molecules in 
the transition state. 
 Intermediates having some stability, often can be detected by physical or 
chemical means, they may even be isolable. Transition states, however, are 
transient species whose properties must be inferred. For example, it is 
reasonable to postulate that the structure of a transition state will be something 
in between the structures of the reactant and the product of a reaction. Another 
useful guide is that the molecular composition of the transition state is given by 
the rate equation. For  example, the rate equation for the alkaline hydrolysis of 
an ester is: 
 V = K [ester] [−OH] 
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 Hence we infer that the transition state includes one ester molecule and 
one hydroxide ion (this is called bimolecular reaction). The molecularity of the 
reaction is the number of molecules of reactants included in the transition state. 
Usually, the molecularity is equal to the order of the reaction, but they may be 
different, as when a bimolecular reaction has a psuedofirst order rate equation. 
 
I.4.2 Effect of the medium 
With the aid of transition state theory we can make useful qualitative 
predictions of the effects on reaction rates and changes in the polarity of the 
solvent (the medium). The polarity of the solvent is related to its ability to 
solvate charged species 
 
According to the transition state theory: 
   A  +  B M
++K+
 
 The polarity of the solvent will affect this equilibrium in the following 
manner: 
− If the transition state is more polar than the initial state then an increase 
in solvent polarity will stabilize (lower the energy of) the transition state 
relative to the initial state, thus increasing the rate. 
− If, on the other hand, the transition state is less polar than the initial 
state, an increase in solvent polarity will decrease the rate. 
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I.4.3 Catalysis 
A catalyst is a substance that increases the rate constant of a reaction but 
does not change the equilibrium constant. In terms of transition state theory, 
therefore, a catalyst makes available a reaction path with smaller change in 
energy of the system. A catalyst can exert its effect by undergoing either 
covalent or monovalent interactions with the reactants.  
 
 
I.4.4 Effect of pH 
The rates of reactions in aqueous solutions are often markedly dependent 
on the solution pH, usually as a consequence of catalytic processes. The study 
of the pH dependence of reaction rates can give insight into the mechanisms of 
the catalysis, and it also yields a very practical information about drug stability. 
The data in such a study will consist of rate constants (usually 
pseudofirst-order constants) as a function of pH, with other factors 
(temperature,  solvent composition) held constant throughout the series of 
measurements. If the pH is kept constant by buffers, it may be necessary to take 
into account the possible catalytic effects by the buffer components. Generally, 
the data can be represented in plots of K against pH or of Log K against pH, 
both forms of data display are called pH-rate profiles ( Keaneth et al. 1984). 
II.0 Pharmacological action of nicardipine 
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Molecular structure of nicardipine hydrochloride. 
Nicardipine, 2-(benzylmethylamino)ethylmethyl-1,4-dihydro-2,6-dimethyl-4-
(m-nitrophenyl)-3,5-pyridine dicarboxylate is a calcium antagonist (Martindale 
2002) used clinically for the treatment of hypertension and angina pectoris. 
Nicardipine causes blockade of the transmembrane inward calcium movement 
resulting in coronary and peripheral vasodilatation. The drug is rapidly and 
extensively metabolized with two main classes of metabolites, namely, those in 
which the dihydropyridine ring remains intact, and those in which oxidation 
occurs. The major urinary metabolites are glucuronide conjugates of alcohol 
metabolites (Graham et al. 1985). 
In humans, intravenous or oral administration of nicardipine results in 
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urinary recovery of < 0.03% unchanged nicardipine. The drug is well tolerated 
with few serious side effects (Rush et al.1986).  
 Zhang and Lai (1991) studied the pharmacology of nicardipine by 
investigating the inhibitory effects of the drug on smooth muscles constriction 
in the Guinea pig via both in vitro and in vivo preparations. From their studies 
they have concluded that nicardipine inhibits broncho constrictor-induced 
constriction of airway smooth muscles both in vivo and in vitro and that, it is a 
potent bronchodilator. 
 In another investigation, Higuchi and Shiobara (1980) studied the 
pharmacokinetics of nicardipine in dogs by using two deuterium labeled 
compounds. The biological half-lives, and systemic availability increased with 
increasing doses of non-labelled nicardipine hydrochloride, while plasma 
clearance decreased, suggesting that the hepatic enzyme activity metabolizing 
the drug was partly saturated by the drug or its metabolites. 
 A good guide to the mode of action of nicardipine is found in the  review 
written by( Stefan et al. 1999). 
 
II.1  Methods of analysis of nicardipine 
 The published methods for the measurement of nicardipine in plasma, 
urine and dosage forms have been reviewed. High performance liquid 
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chromatography (HPLC) is the most frequently adopted method. The reported 
methods are summarized as follows: 
II.1.1 HPLC methods 
 Wu et al. (1984) described a reversed-phase HPLC method for the 
simultaneous determination of nicardipine and its pyridine metabolite in 
plasma. The drug, its pyridine metabolites and an internal standard were 
extracted from plasma and partially purified by acid-base partitioning. Final 
purification and quantitation were achieved by HPLC using a reversed phase 
column and a UV detector (254 nm). The sensitivity of the assay was 5 ng/ml 
for both nicardipine and its pyridine metabolite; and the linear concentration 
range of the assay was 5−150 ng/ml for both compounds. The low coefficients 
of variation (# 5%) for samples spiked with nicardipine and its pyridine 
metabolite in this concentration range demonstrate good reproducibility of the 
assay. The HPLC method was validated against a gas liquid 
chromatography−electron capture detector (GLCΒECD) method which gave 
the combined concentration of nicardipine plus the pyridine metabolite and 
against an HPLC/GC−ECD method, which gave the concentration of the 
pyridine metabolite. All three methods were applied to samples of plasma 
obtained from subjects treated orally with nicardipine hydrochloride. 
 Eastwood et al. (1990) proposed an HPLC method for the measurement 
of nicardipine in plasma and serum. The column effluent was monitored by 
electrochemical detection using a glassy carbon electrode as a working 
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electrode at an applied potential of 1.1 V against Ag/AgCl reference electrode. 
The sensitivity of the method was 2 µg/l and the limit of quantitation was 8 
ng/l. 
 An interesting method for the chromatographic purity and assay of raw 
nicardipine by HPLC was reported by Fernandez et al. (1990). The drug is 
characterized by its photosensitivity and by the presence of impurities formed 
during synthesis. The photodegradation product is the nitropyridine analogue 
and the synthesis impurities are the dimethylester analogue. The HPLC method 
is selective since nicardipine is well separated from the related compounds. 
Furthermore, the method can be applied for stability-indication of nicardipine. 
The chromatographic characteristics and the linearity data for nicardipine and 
the related compounds were not worked out. 
 Maurin et al. (1992) investigated the ionization behaviour of nicardipine 
in presence of 1,4-dihydro-2,6-dimethyl-4(3-nitrophenyl)-3,5-pyridine 
dicarboxylic acid di-2(methyl (phenylmethyl) amino)ethylester (XE820), the 
diamino alcohol ester of nicardipine. The method is an ion-exchange procedure 
which exploited the ionization behaviour of nicardipine and XE820 which 
resulted in an improvement in the sensitivity for the detection of the latter. UV 
detection was employed for measuring the detector response of XE820; and a 
linear range of 0.004 to 8 ng on column was observed. The detection limit and 
quantitation limit were found to be 4 ng and 20 ng, respectively.  
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 Téilting Diaz et al. (1991) described an HPLC method for the 
determination of nicardipine in serum using a carbon fibre flow through 
amperometric detector. A spherisorb cyanopropyl column was used. The 
calibration graph is linear over the range 20-260 µg.ml-1. 
         Li et al. (1998) described a method for the determination of nicardipine in 
plasma and its application to pharmacokinetics in humans by high-performance 
liquid chromatographic method. Nicardipine and nimodipine (internal standard) 
in plasma were extracted with hexane-butanol (2:1, v/v) after addition of borate 
buffer and measured by HPLC using Hypersil C18 column as stationary phase 
and acetonitrile- phosphate buffer- triethylamine as mobile phase. Nicardipine 
was quantified by ultraviolet absorbance at 236 nm. 
 Uno et al. (1997) described an enantioselective HPLC determination of 
nicardipine in human plasma. The (+) nicardipine, (-) nicardipine and (+) 
barnidipine as an internal standard are detected by an ultraviolet detector at 254 
nm. Racemic nicardipine in human plasma was extracted by a rapid and simple 
procedure based on C18 bonded-phase extraction. The extracted samples were 
purified and concentrated on pre-column using a C18 stationary phase and the 
enantiomers of nicardipine were quantiatively separated by HPLC on 
semichiral OA-4500 column containing a chemically modified Pirkle- type 
stationary phase. 
 Meng et al. (1998) reported on the determination of nicardipine in 
human plasma adopting HPLC with nomidipine as an internal standard. An 
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ultrasphere ODS column with 60% acetonitrile in sodium phosphate solution 
adjusted to pH 6.3, as a mobile phase. The detection was achieved 
spectrophotometrically at 254 nm. 
          Bakhtiar and Tse (2000) described a high –throughput chiral liquid 
chromatography/tandem mass spectroscopy to understand  pharmacokinetics of 
each of enantiomers, including potential differences in their absorption, 
distribution, metabolism, and  excretion, using biological fluids and tissue extract. 
             Fernandes and Veiga (2003) described  HPLC for determination of 
nicardipine HCL in rabbit plasma, using nimodipine as internal standard. After 
extraction nicardipine was separated by HPLC on C18 column and quatified by 
ultraviolet detection at 254 nm. A mixture of acetonitrile -0.02M sodium 
phosphate buffer-methanol (45:40:15) with 0.2% triethylamine of pH 6.1 was used 
as mbile phase . 
            Baranda et al. (2006) studied the effect of light on 1,4 dihydropyridine 
calcium channel antagonist  . Methanolic solution have been exposed to laboratory 
and UV light and the stability of the compounds in plasma was tested by exposure 
of spiked plasma sample to laboratory light at room temperature. Products of 
photodecomposition have been identified after forced degradation and the degree 
of degradation has been quantified using LC- UV-DAD and LC-MS-MS 
,respectively. 
           Qi et al. (2006) described a simple and sensitive liquid chromatography-
mass spectrometry method for determination of nicardipine in human plasma. 
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Seperation was achieved on a C18 column, using amobile phase of methanol, water 
and formic acid (320:180:0.4, v/v/v ). 
         Chen et al. (2008) studied the  effect of photoirradiation on nicardipine in 
methanol with Philips 400 UV lamp for 3 h in photochemical chamber. A total of 
four major photoproducts were found from the HPLC chromatogram. 
       
 II.1.2 Gas Chromatographic (GC) methods 
 Higuchi et al. (1975) studied the  GC assay of nicardipine in biological 
fluids. After extraction, nicardipine was oxidized to pyridine analogue with 
nitrous acid and detected by electron capture gas chromatography. The 
sensitivity was 2.3 ng/ml which is sufficient to determine plasma 
concentrations of nicardipine after oral administration of clinical doses to 
humans. 
 A capillary gas chromatographic method with nitrogen-phosphorus 
detection for the simultaneous determination of nicardipine and its pyridine 
metabolite was developed ( Rosseel and Lefebver1994). The method involves 
extraction of the plasma with hexane-methylene chloride (1:1 v/v) followed by 
evaporation of the organic phase. The extract is injected into a fused-silica 
capillary column coated with cross-linked 5% phenyl-methyl silicone. A 
temperature gradient (85-285°C) is applied and the two products and the 
internal standard can be separated within 22 min. The limit of detection is 0.5 
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ng/ml for both products. The method is suitable for pharmacokinetic studies in 
humans. 
 Barbato et al. (1994) reported on the analysis of seven calcium channel 
blockers, including nicardipine and their degradation products by isothermal and 
temperature programming gas chromatography. 
          Ikegaya et al.(2002) detected nicardipine (4.97ug/ml) and its pyridine 
metabolite(5.0 ug/ml) with capillary gas chromatography- mass spectrometry in 
the heart blood of hospitalized patient. 
 
II.1.3 Other chromatographic methods 
 High-Performance Thin-Layer Chromatography (HPTLC) was adopted 
for the determination of nicardipine in capsules. Silica gel 60 F254 plates were 
used with hexane/ethylacetate/ethanol/25% aqueous NH3 as the mobile phase 
and  assessed by ultraviolet at 280 nm.  calibration graph was linear for 
100-400 ng and the percentage recovery was 99.79% (Elgahny et al. 1997). 
 Dihydropyridine calcium channel blockers were separated by Micellar 
Electrokinetic Chromatography (MEKC) on a fused-silica capillary operated at 
60°C with an applied voltage of 24 kV, a running buffer of borax/SDS of pH 8; 
the detection was at 200 nm (Wang et al. 1999). Martinez et al. (1999) applied 
MEKC to the separation and determination of six calcium antagonist, including 
nicardipine, the retention time of the latter was 12.7 min. 
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II.1.4 Electrochemical methods 
 Nicardipine was determined in tablets by a differential pulse 
polarographic method, based on measuring the peak developed at – 0.75 V vs 
Ag/AgCl reference electrode in phosphate buffer of pH 8.07 (Atkosar et al.  
1997). A single-sweep oscillopolarographic method was described for 
nicardipine in its tablets (Wang et al. 1998). The derivative polarographic wave 
was measured at – 0.77 V vs SCE. The percentage recoveries from tablets were 
93.4 to 101.2%. 
 Squella and Nunez-Vergara (1990) studied the polarographic 
determination of calcium antagonists. The developed method was utilized to 
study the photodecomposition of the drugs. In further communications, Squella 
et al (1990 and 1991) applied differential pulse polarography to study the 
photodecomposition of nicardipine. 
 Wang et al.  (1985) studied the electrochemical behaviour of nicardipine at 
viterous-carbon, carbon paste and hanging mercury drop electrodes. The 
differential pulse mode allowed the determination of < 1.0 µm of nicardipine with 
a detection limit of 20 nm. Obendorf and Stubauer (1995) adopted adsorptive 
stripping voltammetry for the determination of nicardipine in plasma and urine. 
The anodic behaviour of nicardipine was also studied (Alvarez-Lueje et al.1994). 
One anodic peak with 2 electrons corresponding to the oxidation of 
dihydropyridine ring was produced. The recoveries from dosage forms were 
91.7-104.3%. El-Jammal et al. (1992) studied the cyclic voltammetry of the 
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calcium antagonists at the vitreous carbon electrode in aqueous 50% methanol. 
The intensity of the peak increased linearly with increasing concentration. 
 A potentiometric method involving the use of ion-selective electrodes was 
reported (Cunningham and Freiser 1984). The Nernstian response was linear over 
the range 10 µm-1.0 mm. Another potentiometric method  based on the use of 
cyanide selective electrode was reported (Zhu et al. 1987). The drug is heated with 
chloroacetic acid for 5 min, treated with ethanolic iodine solution, then the 
potential is measured with a cyanid selective electrode. 
 
II.1.5 Spectrophotometric methods 
 Huang and Li (1990) reported on the determination of nicardipine in its 
tablets by measuring the absorbance of its ethanolic solution at 237 or 354 nm; the 
absorbance-concentration plot is rectilinear over the range 10-40 µg.ml-1. The 
recovery was 100.7 to 101.5%. Rango and Vetuschi (1998) developed a 
UV-derivative spectrophotometric method for nicardipine and its pyridine 
analogue photodegradation product. A micellar modified spectrophotometric 
determination of nicardipine was described (Escrig et al.1998). The method is 
based on the reduction of nicardipine using Sn (II)/HCl, diazotization, then 
coupling with Bratton-Marshall reagent. The produced color was measured at 550 
nm. 
        Rango et al . (2003) described a multicomponent UV spectrophotometric 
method using a classical least- squares algorithm for quantitative determination of 
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1,4- dihydropyridine calcium antagonists and respective photoproducts. 
      Marciniec and  Ogrodowczyk (2006) studied the effect of temperature and air 
humidity on the stability of 7 dereivatives of 1,4-dihydropyridine in solid state by 
using UV spectrophotometric method. 
     
 II.1.6 Miscellaneous methods 
       A method was described for the flow-injection determination of nicardipine 
with amperometric detection by oxidation at the viterous carbon electrode 
(Gonzalez  et al.1988). Calibration graphs were linear for 0.2-16 mg/l. The method 
was applied for its determination in dosage forms. 
 A radioimmunoassay was recommended for nicardipine in human serum 
(Gerbeau and Barradas 1990). Homogenates of rat cardiac membranes were used 
as the drug binding sites. The concentration could be measured over the range 
2.5-320 nm with good precision. Capillary zone electrophoresis was utilized for 
the separation of racemic nicardipines using cyclodextrin (Kato et al. 1997). A 
fused silica column with Tris/phosphate buffer of pH 2.5 was used. The applied 
potential was 15 kV and the detection was affected spectrophotometrically at 254 
nm. 
         Fernandas et al. (2002) studied the inclusion complexation between 
nicardipine , a calcium- channel antagonist ,and β-cyclodextrin in aqueous 
environment and solid state.Complexes were formed in alkaline medium and 
investigated by differential scanning calorimetry, fourier transformation-infrared 
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spectroscopy, X-ray diffractometry and electron microscopy. The dissolution 
profiles were studied in order to define the most appropriate cyclodextrin and 
prepration method to originate inclusion complexes, which will be used in the 
development of a new controlled release formulation of nicardipine. 
           Teraoka et al. (2004) studied the photostability and physicochemical 
properties of nicardipine hydrochloride polymorphs by using Fourier-transformed 
reflection-absorption spectroscopy of the tablets, X-ray powder differaction 
analysis, differential scanning calorimetry and color difference measurement. 
         Kohinata et al. (2004) investigated a method HPLC-differential scanning 
calorimetry to quantitatively  determine amorphous nicardipine in nicardipine –
long acting formula model formulas prepared using nicardipine ,light anhydrous 
silicic acid and carboxymethylcellulose .  
         Pomponio et al. (2004) studied nicardipine –cyclodextrin solid system 
prepared in equimolar ratios and their photostability in aqueous solution under 
exposure to UV (A)-UV (B) radiations. The photodegradation process was 
monitored by capillary electrophoresis method which provided enantioresolution 
of the rac-nicardipine. 
        
II.2 Stability of nicardipine 
Several kinds of preparations have been proposed for the administration of 
nicardipine HCl. Tablets, capsules and coated pellets have been marketed as oral 
extended release formulations. Moreover, ointments and patches for transdermal 
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administration and an intranasal spray solution have been suggested. Among the 
nitrophenyl dihydropyridine derivatives, nicardipine has also been proposed as an 
eye drop formulation for the treatment of glaucoma. 
Bonferoni et al. (1992) studied the photostability of nicardipine upon 
exposure to UV light and daylight adopting HPLC methodology. They 
concluded that the photodegradation kinetics of the methanolic solution of 
nicardipine HCl is a first-order process. A similar study was conducted 
polarographically by Squella and Nunez-Vergara (1990). Realizing that the 
chemical change in a molecule involves the reduction or oxidation of one 
photogroup, producing a change in the redox behaviour of the molecule; they 
utilized polarography to study the photodegradation of calcium antagonists-
including nicardipine. 
 Rango and Vetuschi (1998) studied the photodegrdation of nicardipine 
using fourth-order derivative spectrophotometry. They reported that under the 
influence of light, this drug is broken down by photooxidation of the 
dihydropyridine ring to form the biologically inactive pyridine analogue, which 
is also, the first and main metabolite of the drug. 
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      Recently, Teraoka et al. (2004) studied the photostability and physicochemical 
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properties of nicardipine hydrochloride polymorphs by using Fourier-transformed 
reflection-absorption spectroscopy of the tablets, X-ray powder differaction 
analysis, differential scanning calorimetry and color difference measurement.         
    Pomponio et al. (2004) studied nicardipine –cyclodextrin solid system prepared 
in equimolar ratios and their photostability in aqueous solution under exposure to 
UV (A)-UV (B) radiations. The photodegradation process was monitored by 
capillary electrophoresis method which provided enantioresolution of the rac-
nicardipine. 
    Tadashi (2005) studied difference in nicardipine degradation products content 
among brand- name and generic nicardipine injection. 
     Marciniec and  Ogrodowczyk (2006) studied the effect of temperature and air 
humidity on the stability of 7 dereivatives of 1,4-dihydropyridine in solid state by 
using UV spectrophotometric method.  
    Baranda et al.  (2006) studied the effect of light on 1,4 dihydropyridine calcium 
channel antagonist  . Methanolic solution have been exposed to laboratory and UV 
light and the stability of the compounds in plasma was tested by exposure of 
spiked plasma sample to laboratory light at room temperature. Products of 
photodecomposition have been identified after forced degradation and the degree 
of degradation has been quantified using LC- UV-DAD and LC-MS-
MS,respectively.          
  25
       Chen et al. (2008) studied the  effect of photoirradiation on nicardipine in 
methanol with Philips 400 UV lamp for 3 h in photochemical chamber. A total of 
four major photoproducts were found from the HPLCchromatogram. 
        Walash, et al.(2007) described a simple stability indicating reversed phase 
high performance liquid chromatographic method for determination of nicardipine 
in the presence of its degradation products, using C18 150x 4.6 mm i.d. column 
with UV detection at 238nm. A microemulsion mobile phase consisting of 0.175M 
sodium dodecylsulphate,10% n- propanol,0.3% triethylamine in 0.02M phosphoric 
acid of pH 6.5 was used . 
 
      
 
     
 
 
 
       
 
 II.3  Objectives of the work 
Drug degradation is a serious problem which renders the job of quality 
control analyst very critical. The degradation is usually brought about by any of 
the following methods, namely, oxidation, hydrolysis and photodecay. 
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        Chemically, nicardipine is 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-
3,5-pyridine dicarboxylic acid methyl-2-[methylphenylmethyl) aminomethyl 
ester (Merck index 2001). The presence of the ester linkage in its structural 
formula renders it susceptible to hydrolysis by both acids and alkalies. The 
possible degradation of the drug under such conditions initiated the present 
study. 
        Elucidation of the stability characteristics of nicardipine HCl on exposure to 
light, humidity and other stress conditions is essential to establish the precautions 
required during the development and control of dosage forms. Generally, 
stability of drugs or pharmaceutical preparations depend on temperature, 
concentration, pressure, time, pH, oxygen content, centrifugal or gravitational 
stress, light intensity and wavelength etc. 
Reviewing the literature, revealed that, only the effect of light on the 
stability of nicardipine has been studied. This led  to study the degradation of this 
compound under normal and stress conditions such as elevated temperature, a 
hostel of chemical environment and a combination of these conditions. The aims 
of this work are : 
1. Development of a stability-indicating HPLC method for  
            nicardipine HCl and its degradation products. 
2. To evaluate the kinetic parameters of the degradation reaction of       
             nicardipine hydrochloride.                                      
3. To gain knowledge of the mechanism of its decomposition. 
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4. To isolate and identify the degradation products. 
5. To indicate at what pH the drug is stable. 
 
                                                                                                                     
                                                                                            
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 III.0 Introduction  
The breakdown or degradation of drug substance is usually followed by using a 
suitable analytical method to follow up the concentration of the intact molecule 
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and/or one of its degradants. In this study, the HPLC method was adopted ; 
where losartan was used as the internal standard , the pH was adjusted to 4.5 
.The drug was exposed to stress conditions, such as variation of pH, high 
temperature and humidity . The data obtained was processed and plotted as first 
order, second order or zero order plot. The rate constant, k; order of reaction, n 
were estimated. The dependence of rate on temperature was studied using 
Arrhenious Law (Keaneth et al. 1984). 
 
III.1 Materials, standards and equipments 
III.1.1 Materials 
 Reference Nicardipine Hydrochloride:  Nicardipine HCl (99.84% 
w/w−certified purity),  was purchased from Sigma Chemical Company, St. 
Louis, Mo, U.S.A. 
The supplied material was utilized as reference drug substance without 
further treatments. Full analytical report for the drug was delivered with the 
supplied sample. 
 Nicardipine-containing capsules:  The commercial capsules (Pelcard 50 mg, 
Batch No. ≠ 65801 ) were obtained from commercial sources. The average 
weight was 308mg/capsule. 
 Methanol: BDH Ltd., Spectrosol, Poole-U.K. and from Riedel-de Haën, AG, 
SeelzeΒF.R.G. 
 Acetonitrile: BDH, HiPersolv, Poole−U.K. 
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 Ammonia: aqueous 28% (w/w), E. Merck, Darmstadt, Germany. 
 Distilled water: Bidistilled in all-glass distillator for all analytical purposes 
   Hydrochloric acid:AnalarTM (analytical reagent) Sp. gr. 1.18, BDH Ltd., 
Poole, U.K. 
   Monobasic sodium phosphate  : BDH Ltd., Poole-U.K. 
 Phosphoric acid: Ortho, 85%, E. Merck, Schuchardt, Germany. 
 Ethanol: E. Merck, (Uvasol7), Darmstadt, Germany. 
 TLC-plates: Different precoated TLC-plates. 
− Precoated silica gel 60 (0.25 mm) on glass plates (20 cm Η 20 cm), 
without fluorescent indicator, E. Merck, Darmstadt, Germany. 
− Ready-made silica gel 60 F254 with fluorescent matter (0.20 mm) on 
aluminium (5 cm Η 10 cm) Riedel-de Haën, SeelzeΒF.R.G., or glass 
plates (5 cm Η 10 cm), E. Merck, Darmstadt, Germany. 
 Sodium acetate: Winlab Ltd., U.K. 
 Glacial acetic acid: BDH, AnalaR7, Poole−U.K. 
 Ammonium acetate: BDH, Poole−U.K. 
 Disodium hydrogen orthophosphate: Fluka AG, Switzerland. 
Potassium dihydrogen phosphate: (Riedel de Haën), Germany. 
   Boric acid: BDH, GPR7, Poole−U.K. 
  Sodium hydroxide: Winlab Ltd., U.K. 
  Potassium hydroxide: Merck, Darmstadt, Germany. 
  Losartan :Sigma, St. Louis, Mo, USA. 
  30
  Deuterated solvents: Chloroform (CDCl3) 99.8 atom %D, Winlab Ltd., 
Windsor, Berkshire, U.K. 
 
III.1.2 Standard solutions 
 99.84% w/w Nicardipine hydrochloride reference material was used. A 
standard solution was prepared in distilled water as a stock solution containing 
1.0 mg/ml. This solution was further diluted with the same solvent as 
appropriate. 
 
III.1.3 Equipments 
 IR−Spectrometer: IR−spectrophotometer model 1310, Perkin Elmer, 
Norwalk, U.S.A. The KBr-discs containing the substance (0.5% w/w) were 
prepared by cold compression utilizing a Specac hydraulic vacuum pump, Kent, 
U.K., at −10 tons.cmΓ1. 
 Mass Spectrometer: Finnigan Mat Model 5100 Series. Temperature 
50°C-300°C (eV-70), Finnigan Mat, Paradices Hamel Hempsted, Herts, UK 
 
            Spectrophotometer: A Varian dual-beam DMSΒ90 UV/visible spectro 
photometer with matched 1-cm quartz cells, by Varian Techtron PTY Ltd., 
Australia, was attached to a HewlettΒPackard 7015BXΒY chart recorder, 
California, U.S.A. 
         Humidfier chamber :Pharma 3000. 
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 High Performance Liquid Chromatograph:  
 Shimadzu class –vp v6.LC.-2010A equipped with  UVB50 varian detecter,       
 Rheodyne injecter  and the wave length used was 254nm. 
Column:  
Hypersil, BDS-C18, (5µ ),15cm H 3.9 mm id , Electron corporation 
Thermo , U.S.A. 
 
III.2 Preliminary studies 
III.2.1 Purity assessment of nicardipine hydrochloride 
 Several physico-chemical methods of analysis were applied for the 
determination of nicardipine HCl. The supplied drug substance was 
characterized and analysed before use as a reference material in our studies. 
The sample was subjected to IR-NMR, MS examination. The obtained data 
were matched with those delivered by the manufacturer. 
 
III.2.2 Preliminary exploration of the stability of nicardipine 
 An aqueous solution of nicardipine HCl was heated in a boiling water 
bath in aqueous medium containing either  1 M NaOH or 1 M HCl for 60 
minutes. The UV absorption spectra were recorded along with untreated 
solution containing the same concentration of nicardipine HCl.  
 
III.3 HPLC determination of nicardipine HCl in presence of its 
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degradation products 
 
Instrument 
 The chromatographic apparatus and columns were previously described 
under III.1.3. 
Mobile phase 
 The mobile phase consisted of 20% (v/v) aqueous 0.01 M sodium 
acetate / acetic acid buffer (pH 4.5) and 80% (v/v) acetonitrile. 
Standard solution 
A stock solution of 0.04% (w/v) of nicardipine HCl reference material in 
the mobile phase was prepared and working solutions were prepared by 
appropriate dilution. 
Internal standard 
 A stock solution of 0.02% (w/v) of losartan was prepared in the mobile 
phase and the diluted, working solutions were made accordingly. 
Procedure 
 Construction of calibration curve 
 Appropriate final solutions of 5, 10, 15, 20, 30 and 40 µg/ml of 
nicardipine HCl were made, each standard solution containing 20 µg/ml of the 
internal standard. The detection was accomplished spectrophotometrically at 
254 nm. Three injections, each of 10 µl, were made of each standard solution 
and the mean ratios of peak area responses of nicardipine HCl to that of 
losartan (i.e., peak area of Std/peak area of internal Std) were computed . To 
  33
establish the standard curve, the calculated peak area response ratios were 
plotted vs concentration of nicardipine HCl . Alternatively, the linear regression 
equation was derived.  
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III.4 Study of the factors affecting the degradation kinetics of kicardipine 
HCl 
III.4.1 Effect of strong acids and alkalies 
 The effect of strong acids and alkalies were studied by treating dilute 
samples solutions of nicardipine HCl with initial concentration of 40 µg.ml-1 
(7.75 × 10-5 M) with both sodium hydroxide of different molar concentrations 
(0.1 M, 0.2 M, 0.3 M, 0.4 M and 0.5 M) and 1 M HCl. The experiments were 
conducted at 22± 1°C . Samples were withdrawn and analysed by the 
previously described HPLC method.  The amounts remaining of nicardipine 
were deduced from the calibration graph. 
 
III.4.2 Effect of temperature 
 Solutions of the same concentration of nicardipine HCl (40 µg.ml-1) 
were used to study the effect of temperature. In these experiments, combination 
of the effect of concentration of NaOH and temperature was studied. Solutions 
treated with different concentrations of NaOH were kept at different 
temperatures. Samples were withdrawn at increasing time intervals. The 
samples were analysed for nicardipine HCl content adopting the previously 
described HPLC method.  The reaction rate constants were calculated at every 
temperature and activation energy derived from Arrhenius equation were 
calculated.  
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III.4.3 Effect of buffers 
 The catalytic effect of four buffer systems (citrate, phosphate, borate and 
acetate) of different pH values at 22 ± 1° ,  was studied. The same 
concentration of nicardipine HCl (40 µg.ml-1) was used for the study. 
 
III.4.4 Effect of humidity 
 In this study, nicardipine capsules were used to determine the extent of 
their stability under conditions of high humidity and temperature. The capsules 
were stored in their original containers in humidifier chamber kept at 40°C and 
80% relative humidity. Capsules were taken out of their original containers and 
were wrapped in aluminium foils and placed in plastic vials commonly used for 
dispensing and then stored under the previous conditions. Samples were then 
weekly tested for their nicardipine HCl content adopting the previously 
described HPLC method. The study continued for about 4 months. The results 
are shown in Table 8. 
 
III.5 Isolation of the reaction products 
         0.5 g of nicardipine HCl was dissolved in 100 ml of 0.5 M NaOH then 
heat in a boiling water-bath for 15 hours. Cooled, neutralized with 0.5M HCl 
then extract with chloroform (3 × 5 ml).  chloroform was evaporated to get the 
degradation product II. The aqueous layer was lyophilized for two days to get 
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the degradation product I (admixed with sodium chloride resulting from the 
neutralization of NaOH with HCl).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  37
IV.1 Preliminary Study of the Stability of Nicardipine 
 Chemically, nicardipine is 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-
3,5-pyridine dicarboxylic acid methyl-2-[methylphenylmethyl) aminomethyl 
ester (Merck index 2001). The presence of the ester linkage in its structural 
formula renders it susceptible to hydrolysis by both acids and alkalies. The 
possible degradation of the drug under such conditions initiated the present 
study. 
 In a preliminary study, an aqueous solution containing 8 µg.ml-1 of 
nicardipine was heated in a water bath at 100°C with 1.0 M NaOH and 1.0 M 
HCl for one hour. The absorption spectra of the hydrolysates were compared 
with that of the untreated solution of the same concentration  Fig(.1). Treatment 
with HCl caused the absorption band at 358 nm to disappear completely while 
the band at 240 nm remained almost unchanged. As for the solution treated 
with sodium hydroxide, the absorption band at 240 nm underwent 
hypsochromic shift to 235 nm with hypochromic effect. Meanwhile, the 
absorption band at 358 nm also decreased, with the development of two ill-
defined shoulders at about 330 nm and 270 nm. The decrease in the band at 358 
nm in both acid and alkaline media indicates that, the nitro group is involved in 
the degradation process, probably, it is reduced to the corresponding nitroso 
derivative, (Marciniec and Ogrodowczyk 2006). It is obvious that, a change in 
the chromophoric system of the drug molecule has occurred, and extensive 
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study is needed to enable optimum stability indication of the intact drug 
substance in presence of its degradation products.
  39
 
 
 
 
 
Fig. (1) :absorption spectra of 
- Nicardipine HCL(8mcg/ml ) in aqueous solution. 
- Nicardipine HCL (8mcg/ml) in 1M Na OH. 
- Nicardipine HCL (8 meg/nil ) in 1M HCL 
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IV.2 Purity assessment and content determination of reference 
nicardipine HCl 
 
 The supplied reference drug substance was studied to assess its 
authenticity and to determine its net content. The probable structural changes in 
nicardipine molecule as a result of degradation can be easily elucidated by 
matching with the initial molecular characteristics of the parent drug.  Drug 
purity was checked by different analytical techniques including spectral and 
chromatographic methods. Authenticity of the supplied reference nicardipine 
could be assessed by several analytical techniques such as IR, NMR and Mass 
spectrometry. The results obtained were analysed and matched with those of the 
with-submitted analytical report obtained from the manufacturer. The drug 
content in the supplied drug substance was undertaken by the adopted  HPLC 
method  and it was found to be 99.88±0.15 (Table 1). The reported content 
specifications were 99.84% by the manufacturer’s analytical HPLC procedure. 
Statistical analysis of the data obtained by the proposed method and that 
provided by the manufacturer using the Student’s t-test at 95% confidence level 
revealed no significant difference between the performance of the two methods 
regarding accuracy, (Miller and Miller 2005). 
 
IV.3 Adopted analytical procedure 
 The proposed HPLC method was adopted to follow the kinetics of the 
degradation of nicardipine HCl.  
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Table 1:  Analysis of authentic sample of nicardipine HCl by the adopted 
HPLC method . 
 
µg taken µg found % Recovery Reference method
2.0 1.990 99.50  
4.0 3.998 99.96  
8.0 7.996 99.95  
12.0 11.996 99.97  
16.0 15.990 99.94  
18.0 17.956 99.76  
20.0 19.992 99.96  
24.0 23.980 99.92  
32.0 31.990 99.97  
40.0 39.972 99.93  
X ± SD  Mean 99.88± 0.15  
 
99.84 
t = 0.85 (2.262) 
 
N.B. : 
-  Each result is the average of three separate determinations. 
-  The figure in brackets is the tabulated value of t at p = 0.05 and degree 
of freedom = 9. 
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Losartan proved to be a suitable target as it was eluted after a retention time of 
2.2 minutes without interference with those of any of the intact drug or its 
degradation products which were eluted after 2.90 and 3.30 minutes while the 
nicardipine was eluted after 4.80 minutes Fig.( 2). 
 In order to get better resolution of the peaks, the pH of the mobile phase 
was adjusted to 4.5  . In this way, it was possible to get a nice chromatogram in 
which each the drug, its degradation products and the internal standard were all 
well separated and can be easily quantified. This method can, thus, be 
considered as a stability-indicating one. The system suitabilitydata of the 
proposed method, regarding number of theoretical plates, height equivalent to 
one theoretical plate, resolution, tailing factor and capacity factor are collected 
in( Table 2). The calibration graph was prepared by plotting the peak area ratio 
of standard nicardipine HCl to that of the internal standard versus the 
concentration of nicardipine Fig.( 3). Alternatively, the following regression 
equation was derived. 
 Y = 0.015 + 0.121 x, .............................................................  R2 = 0.9984 
where Y = peak area ratio and x = concentration in µg/ml. 
Statistical evaluation of the data gave a standard deviation of the residual 
(Sy/x) of 0.075, standard deviation of the slope (Sb) of 0.00231 and standard 
deviation of the intercept (Sa) of 0.0348.The limit of detection and 
quantitationwere0.95µ/ml and 2.87µ/ml respectively. These small figures refer 
to the high accuracy and precision of the method (Miller J.C. and Miller J.C 
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2005). The validity of the method was proved by analysing different 
concentrations of nicardipine HCl over the concentration range 5-40 µg/ml. The 
percentage recovery was found to be 99.78±0.17 (Table 3). This value is again 
in agreement with that provided by the manufacture, as revealed by the 
statistical analysis of the data obtained by both methods (Miller J.C. and Miller 
J. N. 2005). 
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Table 2:  system suitability data of the proposed HPLC method. 
 
Compound Retention time (min) 
No. of 
theoretical 
plates 
Height equivalent to 
theoretical plate 
(HETP) 
Capacity 
factor Resolution Tailing factor 
1. Nicardipine HCl. 4.8 4096 0.004 2.90 6.0 1.03 
2. Degradation product I. 2.9 1495 0.01 1.23 2.0 1.1 
3. Degradation prdouct II. 3.3 1936 0.008 1.54 2.0 1.1 
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Table 3:  Analysis of the authentic sample of nicardipine HCl by the proposed 
HPLC method. 
 
µg taken µg found % Recovery Reference Method 
5.0 4.96 99.20  
10.0 9.99 99.90  
15.0 14.97 99.80  
20.0 19.99 99.95  
25.0 24.96 99.84  
30.0 29.95 99.83  
40.0 39.99 99.97 99.84 
X ± SD  99.78 ± 0.17 
 
t = 0.93 (2.4)
 
*Each result is the average of 4 separate determinations. 
*The figure in brackets is the tabulated value of t at p = 0.05. 
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IV.4 Chemical degradation of nicardipine 
 The solutions for studying the kinetics were prepared as in section III.4.1 
&III.2 and analysed by the proposed HPLC method. 
 All reactions were run under pseudo-first order conditions with catalysts 
in excess. The apparent rate constants were obtained from the slopes of 
semilogarithmic linear plots using the least squares method. 
 The degradation was followed by injecting 10 µl volume of the reaction 
mixture containing losartan  as internal standard (20 µg.ml-1). The 
concentration of the intact nicardipine HCl was calculated from the standard 
curve plotted as peak area ratio of standard nicardipine HCl to the internal 
standard versus the concentration of nicardipine Fig.( 3).  
IV.5 Effect of strong acids and alkalies 
i- Effect of acids 
 From the preliminary studies conducted using 1.0 M HCl at 100°C for 
one hour, it was evident that, the drug exhibited some stability compared with 
that of 1.0 M NaOH and this agree with the fact that ester linkages are more 
susceptible to cleavage in alkaline medium than in acid medium ( Keaneth et al. 
1984) . The kinetic parameters for the degradation of nicardipine HCl in acid 
medium were found to be first-order in [nicardipine]. The semi logarithmic plot 
of log (a/a-x) against time (t) was found to be a straight line with a slope of 
0.0006 as shown in Figure (4). Using the formula for the first-order reaction 
kinetics: 
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xa
aKt
−= log303.2 .    
where a is the initial concentration ,x concentration after decomposition. 
the reaction rate constant (K) was found to be 1.38 × 10-3 minutes−1. The half-
life time (t½) was obtained from the following formula: 
 
K
t 693.02/1 =  
and was found to be 502 minutes, i.e., more than 8 hours. 
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ii. Effect of alkalies 
 From the preliminary study conducted on the degradation of nicardipine 
HCl in 1.0 M NaOH at 100°C for one hour, it was evident that the drug 
underwent  decomposition. The chromatogram of the degradate of nicardipine 
showed two peaks in addition to that of the remaining nicardipine It is 
postulated that the decomposition process involves the ester linkage;(Sharma 
and Sharma 1970), like ester hydrolysis of procaine( Keaneth et al), the 
reaction is proposed to proceed as follows: 
N
H
NO2
CH3H3C
CH3OOC COOCH2-CH2-N
CH3
CH2-C6H5
NaOH
N
H
NO2
CH3H3C
CH3OOC COONa HO-CH2-CH2-N
CH3
CH2 C6H5+
I II
1 2
3
4
5
6
 
 
Probably, compound I is eluted first, as it is more polar than either compound II 
or nicardipine itself.  It is possible that, the ester group in the side chain at 
position 5 is also hydrolysed, but, even though, this will not have pronounced 
effect on the chromatogram developed. Study of the kinetic parameters for the  
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degradation of nicardipine involved measuring the peak heights of nicardipine 
and the internal standard only.  
The effect of alkalies on the degradation of nicardipine HCl was studied as in 
section III.4.1 &III4.2. At room temperature it was found that, increasing the 
concentration of sodium hydroxide resulted in increasing the rate of 
degradation. (Table 4) and Fig.(5) show the increase in the value of the reaction 
rate constant (K) and the decrease in the half-life time (t½) upon increasing the 
concentration of sodium hydroxide compared with the hydrolytic degradation 
of nitrendipine and nislodipine (Alvarez –Lueje et al 2000). Fig. (6) is a plot of 
the value of t½ with the concentration of sodium hydroxide. It is evident that the 
t½ decreases linearly with increasing concentration of sodium hydroxide. 
 
Table 4: Effect of concentration of sodium hydroxide on the kinetic parameters 
of nicardipine HCl (40 µg/ml) at room temperature. 
 
Conc. of NaOH (M) Slope K (min−1) t½ (min) 
0.1 0.0005 1.15 × 10-3  601 
0.2 0.0006 1.3818× 10-3  501 
0.3 0.0010 2.30 × 10-3  300 
0.4 0.0012 2.76 × 10-3  250 
0.5 0.0017 3.91 × 10-3  177 
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 The combination of effect of the concentration of sodium hydroxide with 
the effect of temperature was studied by using increasing concentrations of 
sodium hydroxide (0.1-0.5 M) at different temperatures (70-100°C). Figures( 7- 
10)  show the effect of the combination of the two factors at 700, 800, 900 and 
100°C, respectively. (Table 5) is a collection of the data representing the effect 
of increasing the concentration of sodium hydroxide at different temperatures; 
the value of the slopes, reaction rate constants (K, min−1), half-life times (t½, 
min) and activation energy (Ea, K.cal. mol−1) are listed. Fig. (11) shows the 
relation between the values of the reaction rate constants (K) and 
temperature.The data obtained suggested that the rate of degradation of 
nicardipine increases upon increasing both temperature and concentration of 
sodium hydorixde and these results agree with that obtained from the effect of 
temperature on the kinetic parameters of nicardipine (Walash, et al.2007) 
 
IV.6 Effect of temperature 
 The effect of rise of temperature on the rate of reaction is given by 
Arrhenius Law which shows an exponential relation between the rate constant 
(K) and temperature (Keaneth et al.1984). 
 K = A e− Ea/RT 
where K stands for the rate constant. Ea is the activation energy, R is the 
universal gas constant (1.98 Cal/mol-degree) and T is the absolute temperature. 
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Table 5:  Effect of temperature on the kinetic parameters of nicardipine HCl 
(40 µg/ml) at different concentrations of sodium hydroxide. 
 
Conc. of NaOH Tempe-rature °C Slope K (min
−1) Log K t½ (min) 
Ea 
(K. calo.mol−1) 
70 0.0017 3.91 × 10-3  - 2.407 177 
80 0.0021 4.83 × 10-3  - 2.315 143 
90 0.0026 5.98 × 10-3  -2.222 115 
100 0.0039 8.98 × 10-3  - 2.046 77 
 
5.10 
5.40 
10.9 
0.1 M 
     X = 7.13 
70 0.0021 4.83 × 10-3  - 2.315 143 
80 0.0029 6.67 × 10-3  - 2.175 103 
90 0.0036 8.29 × 10-3  - 2.081 83 
100 0.0049 0.01128  - 1.9475 61 
 
7.7 
5.5 
8.5 
0.2 M 
     X = 7.2 
70 0.0025 5.75 × 10-3  -2.239 120 
80 0.0032 7.36 × 10-3  - 2.132 94 
90 0.0042 9.67 × 10-3  - 2.04 71 
100 0.0065 0.0149 - 1.82 46 
 
5.9 
6.9 
11.7 
0.3 M 
     X = 8.2 
70 0.0031 7.13 × 10-3  - 2.14 97 
80 0.0041 9.44 × 10-3  - 2.024 74 
90 0.0058 0.0133 -1.874 52 
100 0.0079 0.01819 - 1.74 38 
 
6.7 
8.9 
8.4 
0.4 M 
     X = 8.0 
70 0.0034 7.83 × 10-3  - 2.106 88 
80 0.0045 0.01036 - 1.984 67 
90 0.007 0.0161 -1.793 43 
100 0.0109 0.0251 - 1.600 28 
 
6.9 
11.1 
11.9 
0.5 M 
     X = 9.97 
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 Systemic studies were carried out, Fig.(12-16) show the effect of 
temperature on the degradation of nicardipine HCl over the range 700 to 100°C 
 of constant concentrations of sodium hydroxide of 0.1, 0.2, 0.3, 0.4 and 0.5 M, 
respectively. The rate constant at each temperature was determined from a 
suitable plot, and Log K was plotted against the reciprocal of temperature (1/T). 
From the slope of such plots, the activation energy was calculated as shown in 
Fig. (17). The magnitude of the activation energy measures the energy barrier 
separating reactants from products. The smaller the value of the activation 
energy, the easier is the crossing of the energy barrier, and hence the 
occurrence of the reaction is more likely. The reaction rate constant was 
calculated at each temperature and the activation energy was calculated from 
the following relation: 
 
21
12
1
2
303.2
)(
TRT
TTE
K
KLog a −=  
where K2 and K1 are the rate constants at T2 and T1, respectively.(Keaneth et al 
1984). 
 The values of activation energy at each temperature range are abridged 
in (Table 5). 
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IV.7 Effect of Buffers 
 The buffer is used to maintain the pH during the study. However, certain 
types of buffers e.g. citrates and to a less extent phosphates exert general acid 
and general base catalysis ( Keaneth et al 1984). 
 The effect of type and concentration of buffers on the reaction rate 
constant is shown in (Fig.18) and (Table 6). Using phosphate and citrate buffer 
of the same pH value (4.5) and equal concentrations at room temperature, the 
reaction rate constant was found to be higher in case of citrate than the 
corresponding concentration of phosphate. Fig.(19-22) and (Table7) 
demonstrate the effect of different buffers with different pH values on the rate 
of degradation of nicardipine at 100°C. From these figures the following 
conclusions are drawn: 
- For the same type buffer: increasing the pH will increase the rate 
degradation. 
 -       Citrate buffers increase the rate of degradation more than 
phosphate more than borate and finally acetate.The acetate buffer has no 
effect on the degradation of nicardipine so it can be used in  methods to 
investigate the stability of dosage form and for the development and 
validation of quantitative method for therapeutic drug monitoring with 
plasma sample.  The pH-rate profile of nicardipine hydrochloride is 
shown in fig.(23). 
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Table 6: The calculated pseudofirst order rate constant (Kobs) and half-lives of 
degradation of nicardipine. HCl at various pH values at room temperature 
(22°C). 
 
pH Buffer composition Kobs day
–1 Half life t½ (day) Log Ko 
1.1 HCl 4 × 10–2 17.30 – 1.40 
2.45 Acetate 1.92 × 10–3 155.00 – 2.71 
3.40 Citrate 1.5 × 10–3 462.00 – 2.82 
4.50 Citrate 8.91 × 10–4 777.00 – 3.05 
5.20 Citrate 1.41 × 10–3 491.00 – 2.85 
6.00 Citrate 0.564 × 10–1 8.62 – 0.23 
7.00 Phosphate 27.7 × 10–1 17.50 – 0.56 
8.30 Borate 0.1 × 10–1 6.93 – 1 
9.00 Borate 0.316 × 10–1 2.19 – 0.50 
10.00 Borate 1.58 0.46 0.19 
11.20 NaOH 6.58 0.21 0.81 
13.00 NaOH 1.09 × 10–3 0.44 –2.96 
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Table 7: Comparison between the different buffer system on the degradation of 
nicardipine (40 µg/ml) at 100°C. 
 
Type of Buffer K (min-1) Log K t1/2 (min) 
Citrate buffer pH 6 0.0154 -1.81 44.91 
Citrate buffer pH 5.2 0.0108 - 1.96 64.00 
Citrate buffer pH 4.5 0.0069 - 2.11 100.00 
Phosphate buffer pH 9 0.0159 - 1.79 43.61 
Phosphate buffer pH 8 0.013 -1.88 52.79 
Phosphate buffer pH 7.5 0.011 -1.95 61.41 
Phosphate buffer pH 6.5 0.0092 -2.04 75.22 
Borate buffer pH 10 0.014 -1.85 49.33 
Borate buffer pH 9 0.011 -1.96 62.69 
Borate buffer pH 8 0.0089 -2.04 77.16 
Acetate buffer pH 5.5 0.0076 -2.12 91.00 
Acetate buffer pH 4.5 0.0041 -2.38 167 
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IV.8 Effect of Humidity and Temperature on Capsules 
 Storage of pharmaceutical dosage forms under adverse conditions of 
temperature and humidity in many parts of the world is not common. Drugs 
prone to hydrolytic decomposition could be affected as far as the drug content 
is concerned. The purpose of this study was to examine the effect of high 
relative humidity coupled with high relative temperature on the content of 
nicardipine hydrochloride in capsules. 
 (Table 8) assembles the percent content of nicardipine HCl during the 
period of investigation. The figures in the table reveal that nicardipine HCl in 
capsule dosage forms was not affected by 80% relative humidity at 40°C. the 
content of nicardipine HCl remained practically constant over the period of 
study. This indicates that nicardipine HCl resists hydrolytic decomposition 
under the conditions of relatively high humidity and temperature. The study 
period may be extended further to check the inferences reached so far. 
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Table 8: Effect of humidity on the degradation of nicardipine capsules at 40°C. 
 
Time (week) % Content of nicardipine 
1 99.80 
2 99.80 
3 99.80 
4 99.78 
5 99.77 
6 99.77 
7 99.77 
8 99.75 
9 99.75 
10 99.75 
11 99.74 
12 99.73 
13 99.72 
14 99.69 
15 99.67 
16 99.65 
17 99.65 
 
Each result is the average of 4 separate determinations. 
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IV.9 Study of the reaction products 
 Treatment of nicardipine with sodium hydroxide at elevated temperature 
resulted in cleavage of the ester linkage and the production of two compounds, 
I (acid) and II (alcohol) as shown below: 
N
H
NO2
CH3H3C
CH3OOC COOCH2-CH2-N
CH3
CH2-C6H5
NaOH
N
H
NO2
CH3H3C
CH3OOC COONa HO-CH2-CH2-N
CH3
CH2 C6H5+
I II
1 2
3
4
5
6
∆
 
 TLC of the neutralised hydrolysate using a mobile phase consisting of 
chloroform: methanol (9.5:0.5) gave two spots, one with Rf value of 0.7 while 
the other remained on the base line. The first spot is supposed to be the alcohol 
fraction (II) being less polar than the second one (I), which remained on the 
base line. 
 Extraction of the neutralised hydrolysate with chloroform followed by 
evaporation gave a residue for compound (II). The infrared spectrum of that 
compound is shown in Fig. (24). (Table 9) shows the IR characteristics of the 
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compound. The mass spectrum is also shown in Fig(.25) and (Table10) 
abridges the assignment of the mass fragments. 
 Compound (I), the acid fraction (present as sodium salt) is highly polar 
and could not be isolated by extraction. It could not also be precipitated from 
the reaction mixture neither on acidification nor upon alkalinization, probably 
because it possesses acidic and basic functional groups, which render it soluble 
in both media. 
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Table 9:  Infrared characteristic of degradtion product II. 
 
Wave number cm-1 Assignment 
3420-3260 O-H stretch. 
3100-3000 Aromatic C-H stretch 
2900-2680 Aliphatic C-H stretch 
1920-1850 Overtone bands. 
1600-1520 C CRing stretch  
1500 and 1420 O-H vibration 
1350 C-N stretch (tertiary amine) 
1220 C-O stretch 
750 Out-of-plane C-H bend. 
660 Out-of-plane C-C bend. 
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Table 10:ssignment of mass fragments of the degradation product II. 
 
Mass peak (m/e) Relative intensity Assignment 
165 1.9% 
HO CH2CH2 N
CH3
CH2
+
Molecular peak M+  
 
43 100% NCH2 CH3
+
 
91 80% +
 
57 76% N
CH3 +
 
134 27% N CH2
CH3
CH2
+
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IV.10   CONCLUSION 
 Nicardipine hydrochloride degradation has been investigated under 
various experimental conditions. Firstly: the decomposition has been carried 
out under various pH values ranging from acidic to alkaline (i.e. pH 1.1 to 11.2) 
using phosphate, acetate citrate and borate buffers. The drug was found to be 
most stable at pH = 4.5 . 
 The energy of activation calculated from Arrhenius plot suggests that a 
typical hydrolytic reaction is involved. The rate of the decomposition increases 
considerably in the alkaline medium.  
 The catalytic effect of four buffers, namely, phosphate, borate, citrate 
and acetate buffer indicated that the citrate exerts a more catalytic activity than 
the other three buffers of which acetate apparently has no effect on the rate of 
degradation of nicardipine hydrochloride. 
 The investigation of the effect of relative humidity of 80% at 40C0  
using nicardipine capsules indicated that the content of the active ingredient 
remained constant over the period of study. 
The hydrolytic products were identified and isolated. 
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IV.11  RECOMMENDATION 
1- Since nicardipine was found to be stable at pH 4.5 and 
acetate buffer exerts no effect on degradation , this would 
provide a good knowledge to formulate anew  liquid dosage 
form. 
2- Elucidation of chemical kinetics is a value in solving 
practical stability problems or to make decisions on the shelf-
life of the pharmaceutical products. 
3- Investigations of stability characteristic is essential to 
establish the precautions required during the development and 
control of dosage form as well as development and validation of 
quantitative method for therapeutic drug monitoring  
4- The drug can be stored  in its original container at the 
recommended storage condition (below 30ºC).  
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